BioCentury
ARTICLE | Clinical News

MVA F6 tyrosinase: Began Phase I/II trial

July 3, 2000 7:00 AM UTC

Bavarian Nordic Research Institute A/S (CSE:BNRI), Glostrup, Denmark Product: MVA F6 tyrosinase Business: Cancer Therapeutic category: Gene therapy, Immune stimulation Target: Tumor cells Description...